Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and tumor-shrinking ability of experimental medication BMS-986179 alone and when combined with Nivolumab, in patients with solid cancers that are adva...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT04145622 · Advanced Solid Tumor, Malignant Solid Tumor
NCT07326488 · Advanced Malignant Solid Tumor
NCT06658951 · HER2-positive Advanced Malignant Solid Tumors
NCT07028281 · Malignant Solid Tumors
NCT07293754 · Advanced Malignant Solid Tumor
Local Institution - 0028
Chicago, Illinois
Local Institution - 0001
Baltimore, Maryland
Local Institution - 0022
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions